Literature DB >> 525434

Risk factors for myocardial infarction in the Stockholm prospective study. A 14-year follow-up focussing on the role of plasma triglycerides and cholesterol.

L A Carlson, L E Böttiger, P E Ahfeldt.   

Abstract

A 14-year follow-up of the Stockholm prospective study is reported. A number of 130 new myocardial infarctions (MI) were found in a prospective group of men (n = 3189) and another 46, i.e. a total of 176 MI, in the total group (n = 3486). Different types of multivariate statistical analyses show that age, blood pressure, smoking, fasting plasma concentrations of cholesterol and triglycerides, ESR and Hb were independent risk factors for MI, while the weight/height index was not. Elevated BP became an important risk factor only after the age of 50. When only age, BP, smoking and the two plasma lipids were entered into the logistic multivariate analysis, plasma triglycerides were more important as a risk factor than cholesterol. Quintile analysis showed that the rate of new MIs increased more with increasing triglyceride than increasing cholesterol levels. In the prospective group, the average rate of new MIs for men below 60 years was 32 per 1000. In the bottom and top quintile these rates were 16 and 65 for plasma triglycerides and 27 and 47 for cholesterol. When the men were divided into 4 groups with regard to both plasma lipids, the rate of new MIs increased successively from group to group along this chain: both lipids normal, only cholesterol high, only triglycerides high and both plasma lipids high.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 525434

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  32 in total

Review 1.  Postprandial lipemia and coronary risk.

Authors:  W Patsch; H Esterbauer; B Föger; J R Patsch
Journal:  Curr Atheroscler Rep       Date:  2000-05       Impact factor: 5.113

2.  Effects of doxazosin and atenolol on the fibrinolytic system in patients with hypertension and elevated serum cholesterol.

Authors:  J H Jansson; B Johansson; K Boman; T K Nilsson
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  Contributions of de novo synthesis of fatty acids to total VLDL-triglyceride secretion during prolonged hyperglycemia/hyperinsulinemia in normal man.

Authors:  A Aarsland; D Chinkes; R R Wolfe
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

Review 4.  Micronised fenofibrate: a review of its pharmacodynamic properties and clinical efficacy in the management of dyslipidaemia.

Authors:  J C Adkins; D Faulds
Journal:  Drugs       Date:  1997-10       Impact factor: 9.546

5.  Cholesterol and triglyceride reference ranges in the Republic of Ireland.

Authors:  W P Tormey
Journal:  Ir J Med Sci       Date:  1988-02       Impact factor: 1.568

6.  Beta blockers, lipids, and coronary atherosclerosis: fact or fiction?

Authors:  R J Northcote
Journal:  Br Med J (Clin Res Ed)       Date:  1988-03-12

7.  Fibrinogen: A new cardiovascular risk factor?

Authors:  M C Petch
Journal:  Can Fam Physician       Date:  1993-05       Impact factor: 3.275

8.  Ischaemic heart disease: association with haematocrit in the British Regional Heart Study.

Authors:  G Wannamethee; A G Shaper; P H Whincup
Journal:  J Epidemiol Community Health       Date:  1994-04       Impact factor: 3.710

9.  Effects of low dose oral contraceptives on very low density and low density lipoprotein metabolism.

Authors:  B W Walsh; F M Sacks
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

10.  A Relationship between the Obstructive Sleep Apnea Syndrome and the Erythrocyte Sedimentation Rate.

Authors:  Jin-Young Min; Jeon Yeob Jang; Hyo Yeol Kim; Won Yong Lee; Hun-Jong Dhong; Seung Kyu Chung; Soo-Chan Chung
Journal:  Clin Exp Otorhinolaryngol       Date:  2009-09-23       Impact factor: 3.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.